Preclinical Evaluation of Invariant Natural Killer T-Cells in the 5T33 Multiple Myeloma Model

Blood - United States
doi 10.1182/blood.v120.21.938.938
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

A Model of Multiple Myeloma: Culture of 5T33 Murine Myeloma Cells and Evaluation of Tumorigenicity in the C57bl/KaLwRij Mouse

British Journal of Cancer
Cancer ResearchOncology
1992English

Lineage Differentiation Program of Invariant Natural Killer T Cells

Immune Network
Infectious DiseasesImmunologyAllergy
2017English

Therapeutic Potential of Invariant Natural Killer T Cells in Autoimmunity

Frontiers in Immunology
AllergyImmunology
2018English

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy

Frontiers in Immunology
AllergyImmunology
2017English

Osteopontin Regulates Development and Function of Invariant Natural Killer T Cells

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Thio-Isoglobotrihexosylceramide, an Agonist for Activating Invariant Natural Killer T Cells

English

Invariant Natural Killer T Cells Are Functionally Impaired in Patients With Systemic Sclerosis

Arthritis Research & Therapy
2019English

Invariant Natural Killer T (iNKT) Cell Exhaustion in Sarcoidosis

European Journal of Immunology
AllergyImmunology
2013English

Contrasting Roles for Vα14+natural Killer T Cells in a Viral Model for Multiple Sclerosis

Journal of NeuroVirology
VirologyNeurologyCellularMolecular Neuroscience
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy